Breaking News

Almac Passes MHRA Inspection at Charnwood Facilities

Can develop, make and pack non-potent and potent, solid orals for clinical trials and commercial supply

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Almac Group has successfully completed an inspection by the UK Medicines and Healthcare products Regulatory Agency (MHRA) of its new Pharmaceutical Development & Manufacturing facilities at Charnwood Campus, in Loughborough England.   In November 2015, the company began an expansion of its pharmaceutical development and manufacturing services with the acquisition of a significant proportion of the 70-acre Charnwood Campus, a science and technology park. The facilities have since undergone ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters